• Mashup Score: 0

    Formed in 2019, The Amyloidosis Forum has been developed through a public-private partnership between the Amyloidosis Research Consortium (ARC) and the US Food and Drug Administration (FDA). The overarching goal of the Forum is to optimize innovation and accelerate the advancement of new therapeutics by addressing scientific gaps and needs through the conduct of mutually beneficial scientific…

    Tweet Tweets with this article
    • Learn more about our work with FDA, the #AmyloidosisForum, here: https://t.co/cCtzX4sdBL

  • Mashup Score: 2

    Create your profile, find a challenge, and start solving! Join a team or form your own, or go solo. Always free, always open.

    Tweet Tweets with this article
    • Here's how to VOTE TODAY: 1. Go to https://t.co/Lo0sqpU19q 2. Create a free HeroX account 3. Click the "Vote for this submission" button on the HeroX website 4. Click "Yes" 5. Enter your phone number (HeroX's verification system to make sure only one vote per person is cast)

    • VOTE TODAY and help our #AmyloidosisForum submission to the HeroX #DataWorks challenge win the people's choice recognition award! Only the TOP TWO submissions win and we're currently in THIRD place. We need you! Regiester and vote here: https://t.co/Lo0sqpUyYY #amyloidosis https://t.co/nJm58uJ0jW

  • Mashup Score: 0

    Recording of the Afternoon Sessions from the Amyloidosis Forum: Potential Pathways for Development of Imaging Endpoints for Clinical Trials in AL and ATTR Am…

    Tweet Tweets with this article
    • Recordings from @Amyloidosis_ARC #Amyloidosisforum @US_FDA imaging endpoints meeting are posted now I discussed #HCM & #mavacamten RCTs as a case study for #ATTR #amyloidosis-watch here https://t.co/PqNWVyfXws https://t.co/wR76V0apfg #CardioTwitter #echofirst #whycmr #cvnuc